Cite

HARVARD Citation

    Tan, D. et al. (n.d.). 71OPhase I extension study of ETC-159 an oral PORCN inhibitor administered with bone protective treatment, in patients with advanced solid tumours. Annals of oncology. p. . [Online]. 
  
Back to record